SIFTED – Clinical trials need a revamp — could Europe lead the charge?

Clinical trial costs are surging, contributing to higher R&D expenditures, and subsequently driving up healthcare costs. Strategikon, the latest addition to our Innovation Fund’s investment portfolio, can assist the pharmaceutical industry in planning, budgeting, and sourcing trials. By streamlining processes and establishing new benchmarks, Strategikon brings much-needed price transparency to the forefront of the industry, offering the potential to lower costs, increase efficiency, and ultimately improve patient access to life-changing therapies.

Discover more here